Recruiting Heart Attack Studies in Ithaca
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed originator study, clinical study LOXO-BTK-18001/J2N-OX-...
About Heart Attack Clinical Trials in Ithaca
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Ithaca, NY. These studies are seeking a combined 1,066 participants. Research is being sponsored by Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Ithaca — FAQ
Are there heart attack clinical trials in Ithaca?
Yes, there are 2 heart attack clinical trials currently recruiting in Ithaca, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ithaca?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ithaca research site will contact you about next steps.
Are clinical trials in Ithaca free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ithaca studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Ithaca are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov